US FDA Reports, Use of Some Diabetes Drugs Linked to Acute Gallbladder Disease
In a recent study, the US Food and Drug Administration (FDA) its review of the FDA Adverse Event Reporting System (FAERS). The review was conducted to identify the cases of acute cholecystitis (AC) linked to the intake of glucagon-like peptide-1 (GLP-1) agonists, which do not have precautions for acute gallbladder disease. The study found 36 […]
Continue Reading